| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |